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Abstract Annexin VI is a Ca2+-dependent membrane and
phospholipid binding protein. It mediates a protein-protein
interaction with the Ras p21 regulatory protein p120GAP. In this
study we have mapped the binding site of GAP within the
annexin VI protein. Using Far Western overlay binding assays
and cell lysate competition studies we have mapped the site of
interaction to the inter-lobe linker region; amino acids 325^363.
Finally, using a GST fusion protein corresponding to this linker
region we have demonstrated that cellular loading of the fusion
protein into Rat-1 fibroblasts by electroporation blocks the
interaction and co-immunoprecipitation of annexin VI and GAP.
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1. Introduction
Annexins are a family of structurally related Ca2-depend-
ent phospholipid and membrane binding proteins. To date, at
least 13 have been identi¢ed and cloned [1,2]. The crystal
structure of both bovine and human annexin VI have been
determined [3,4] and from these studies and molecular mod-
elling it is apparent that the protein consists of two disk-
shaped lobes and an inter-lobe connecting region. Each lobe
contains four structural repeats of approximately 70 amino
acid residues and the lobes are positioned perpendicular to
each other. Each repeat forms a structural domain comprised
of ¢ve K-helices and a number of Ca2 binding sites have been
proposed within loops located between speci¢c helices within
these repeat structures. Intriguingly, Ca2 binding is predicted
to occur on a convex surface of the protein which is proposed
to bind to cellular membranes [4].
Although much is known about the structure of annexin
VI, the precise cellular functions of the protein have yet to
be established. The protein displays a wide tissue expression
pro¢le and is detectable in cells at abundant levels associated
with the plasma membrane and internal membrane systems
[5^8]. A range of cellular functions have been proposed for
the protein including Ca2 and K conductance modulation,
[9], Ca2 homeostasis [10] and cellular growth and prolifera-
tion [11,12].
Recently, we have shown that annexin VI interacts directly
with a key Ras regulatory protein p120-GTPase activating
protein (p120GAP) [13]. In addition, we have established that
it is the conserved region 2 (C2) domain within GAP which
interacts with annexin VI. We and others have demonstrated
that C2 domains within proteins have the ability to bind neg-
atively charged phospholipids in a Ca2-dependent manner
[14,15] and the C2 domain within GAP has the ability to
co-bind to phospholipid vesicles and cellular membranes in
a Ca2 and annexin VI dependent manner [16]. Our observa-
tions have led us to propose that the annexin VI-GAP inter-
action may play a role in the ability of GAP to translocate
and membrane associate in response to intracellular Ca2 el-
evation [16,17].
Here we have attempted to de¢ne the region within annexin
VI where the C2 domain of GAP interacts. As a result of this
study it will be possible to design both mutant proteins and
smaller peptides corresponding to stretches within the inter-
action region in order to selectively disrupt this protein-pro-
tein interaction. Thus, by designing such tools, the cellular
consequences of such a disruption may be evaluated and a
cellular signalling function ascribed to the annexin VI protein.
2. Materials and methods
2.1. Materials
Unless otherwise stated, all reagents were of analytical grade. Re-
striction endonucleases were purchased from New England Biolabs
(Herts, UK), glutathione-agarose beads, anti-GST antibodies, throm-
bin, X-Omat Kodak X-ray ¢lm were purchased from Sigma. Factor
Xa was purchased from Promega. pGEX expression system was pur-
chased from Pharmacia. Tissue culture media and supplements were
purchased from GIBCO BRL. Oligonucleotides for fusion protein
construction and sequencing were synthesised by GENOSYS Biotech
(Europe). Anti-rabbit horseradish peroxidase (HRP)-conjugated sec-
ondary antibodies and sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) molecular weight markers were pur-
chased from Bio-Rad. Anti-GAP antibodies were purchased from
UBI.
2.2. Construction, expression and puri¢cation of GST fusion proteins
GST fusion proteins encoding amino acids 606^648 of human GAP
(GSTGAP C2) and amino acids 1^673 of human annexin VI (GSTan-
nexin VI1ÿ673) were constructed as previously described [13]. cDNA
encoding GSTannexin VI1ÿ673 was digested with BglII to yield frag-
ments corresponding to amino acids 118^292, 292^421 and 421^529 of
human annexin VI. Fragments were subcloned into a BamHI digested
pGEX-3X vector to yield the GST fusion proteins GSTannexin
VI118ÿ292, GSTannexin VI292ÿ421 and GST annexin VI421ÿ529. A
cDNA fragment encoding for amino acids 383^673 of annexin VI
was PCR ampli¢ed using oligonucleotide primers: 5P-AAGACA-
CAATCATCGATAT CATCA-3P and 5P-CTACTACT AGGGCC-
CCT AGTCCTCACC-3P. The 3P-reverse primer contained an ApaI
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restriction site to facilitate subcloning (underlined). The PCR product
was digested with ApaI, Klenow blunted and subcloned into a SmaI
digested pGEX-3X vector. The vector containing insert was then di-
gested with BamHI and re-ligated to yield GSTannexin VI500ÿ673.
Annexin VI325ÿ363 was ampli¢ed by PCR from GSTannexin VI1ÿ673
using the following primers; 5P-TGATGATGAGGATCCGATGCT
GCTGGCCAT CTT-3P (containing a BamHI site, underlined) and
5P-TCATATCAGAATTCCTTCAGCTC TACTCGGGCCA-3P (con-
taining an EcoRI site, underlined). The PCR product was BamHI/
EcoRI digested and subcloned into a BamHI/EcoRI digested pGEX-
2T vector, generating GSTannexin VI325ÿ363. Fusion protein con-
structs were veri¢ed by DNA sequencing.
2.3. Expression and puri¢cation of GST fusion proteins
All GST fusion proteins were expressed in XL1-Blue Escherichia
coli, as described previously [14]. GSTGAP C2, GSTannexin
VI1ÿ673, GSTannexin VI421ÿ529 and GSTannexin VI325ÿ363 were puri-
¢ed as previously described [13]. Bacterial cultures expressing GSTan-
nexin VI118ÿ292and GSTannexin VI500ÿ673 were centrifuged at 3000Ug
for 15 min at 4‡C and the pellet resuspended in 15 mM HEPES pH
7.5 containing 5 mM ethylene glycol-bis(L-amino ethyl ether)-
NPNPNP,NP-tetra-acetic acid (EGTA), 1 mM phenylmethylsulfonyl £u-
oride (PMSF) and free Ca2 at a concentration of 7 mM. The cells
were sonicated on ice for 3U30s and centrifuged at 14 000Ug for 30
min at 4‡C. The pellet was washed twice in the calcium containing
bu¡er and ¢nally incubated on ice for 30 min following resuspension
in 15 mM HEPES pH 7.5 containing 5 mM EGTA and 1 mM PMSF.
Cells were centrifuged at 14 000Ug for 30 min at 4‡C. The super-
natant was collected and puri¢ed on glutathione-agarose beads. A
bacterial culture expressing GSTannexin VI292ÿ421 was centrifuged at
Fig. 1. Expression and detection of GST fusion protein constructs. A: Schematic diagram representing the amino acid boundaries for the
GSTannexin VI fusion proteins. B: Coomassie-stained SDS-polyacrylamide gel of the puri¢ed GSTannexin VI fusion proteins. C: Coomassie-
stained SDS-polyacrylamide gel of Factor Xa cleaved annexin VI protein fragments. D: Cleaved fragments were not detected with anti-GST
antibodies. E: Cleaved annexin VI fragments were detected with anti-annexin VI antibodies.
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3000Ug for 15 min at 4‡C and the pellet resuspended in 25 mM Tris
pH 7.5. Five miligram lysozyme was added and the resuspended pellet
incubated shaking at 4‡C for 30 min. Cells were sonicated and cen-
trifuged as before. The pellet was washed with 25 mM Tris pH 7.5
containing 2% Triton X-100, incubated shaking at room temperature
for 30 min in 25 mM Tris pH 7.5 containing 8 M Urea, 1% L-mer-
captoethanol, 0.1% SDS and 1% glycerol. The solubilised protein was
diluted 1:20 with ice cold 25 mM Tris pH 7.5, followed by centrifu-
gation at 14 000Ug for 15 min at 4‡C.
2.4. Cleavage of GST fusion proteins
Annexin VI1ÿ673 was thrombin cleaved from GSTannexin VI1ÿ673
as previously described [16]. As appropriate recombinant annexin
VI1ÿ673 was cleaved with V8 protease at a protease:protein (w/w) ratio
of 1:20 for 2 h at 25‡C and puri¢ed by electroelution. GSTannexin
VI118ÿ292, GSTannexin VI292ÿ421, GSTannexin VI421ÿ529 and GSTan-
nexin VI500ÿ673 were cleaved by incubating puri¢ed fusion protein
with Factor Xa at a protease:protein (w/w) ratio of 1:50 for 4^6 h
at 25‡C with constant agitation.
2.5. Detection of Factor Xa cleaved annexin VI protein fragments
Cleaved fragments were resolved by SDS-PAGE, Western trans-
ferred and blots were blocked in 5% (w/v) skimmed milk powder in
phosphate bu¡ered saline (PBS). Blots were probed with either anti-
annexin VI [13] or anti-GST antibodies diluted 1:200 (v/v) and 1:1000
(v/v), respectively in 5% (w/v) skimmed milk powder in PBS. Bound
antibody was detected with goat anti-rabbit HRP conjugated secon-
dary antibodies and visualised using enhanced chemiluminescence
(ECL) and X-omat AR grey ¢lm.
2.6. Overlay assay with cleaved annexin VI fragments
Two-hundred nanomol of Factor Xa or V8 protease cleaved frag-
ments were subjected to SDS-PAGE and transferred to nitrocellulose
membranes. Blots were blocked in 5% (w/v) skimmed milk powder in
PBS for 1 h and incubated with either 30 nM GST or 30 nM
GSTGAPC2 as previously described [13]. Filters were then probed
with anti-GST polyclonal antibodies and bound antibody detected
with anti-rabbit-HRP and ECL.
2.7. Competitive displacement of annexin VI protein fragment binding
with free annexin VI protein
Two-hundred nanogram (14 pmol) of puri¢ed annexin VI292ÿ421
(per gel lane) was resolved by SDS-PAGE and transferred onto nitro-
cellulose membranes. Blots were blocked in PBS at 25‡C for 1 h and
incubated with either 420 nM annexin VI1ÿ673, 30 nM GSTGAPC2 or
30 nM GSTGAPC2 and 420 nM annexin VI1ÿ673 at 25‡C for 1 h with
constant agitation. Bound fusion protein was detected with anti-GST
polyclonal antibodies followed by probing with goat anti-rabbit-HRP
antibodies and ECL.
2.8. Immunoprecipitation studies in Rat-1 ¢broblasts/peptide
competition assay
Rat-1 ¢broblasts were maintained as previously described [13]. Pri-
or to harvesting, cells were washed twice with PBS and lysed on ice
with 20 strokes in a Dounce homogeniser. Cell suspensions were then
centrifuged at 1000Ug to remove nuclei and unbroken cells. Immu-
noprecipitation studies were essentially carried out as previously de-
scribed [13] with the exception that cells were either lysed in RIPA
bu¡er and cell lysates incubated with the antibody-bead complex in
Fig. 2. A: Far Western overlay binding assay demonstrates recombinant full length annexin VI binds GSTGAP C2 and not GST. B: The an-
nexin VI protein fragments do not bind GST. C: Annexin VI292ÿ421 binds to GSTGAP C2.
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the presence or absence of either 0.42 WM GST, 0.42 WM GSTannexin
VI292ÿ421 or else 0.54 WM GST or GSTannexin VI325ÿ363 loaded into
cells by electroporation. Immunoprecipitated samples were analysed
by SDS-PAGE, Western blotting and probed with anti-GAP and anti-
annexin VI antibodies.
2.9. Electroporation of GSTannexin VI325ÿ363 into Rat-1 ¢broblasts
Cells were harvested by trypsinisation. After supplementation with
10% (v/v) foetal bovine serum (FBS), ¢broblasts were then washed
twice with DMEM lacking FBS and resuspended to 1 ml with
DMEM lacking FBS. The cells were then placed on ice for 10 min.
1 WM GST or GSTannexin VI325ÿ363 were then added to the cells and
the resulting cell suspension transferred to an ice-cold sterile 0.4 mm
electrode electroporation cuvette. A single pulse of 800 V was dis-
charged across the cuvette and the cuvette incubated on ice for 10
min. The cells were gently pipetted into a 10 cm tissue culture plate
and incubated with DMEM supplemented with 10% (v/v) FBS, 10 000
units/l penicillin, 10 000 Wg/l streptomycin, 4 mM glutamine and al-
lowed to recover overnight in a 5% CO2 atmosphere prior to use.
3. Results
3.1. Construction and puri¢cation of GST annexin VI fusion
proteins
In order to map the site of interaction within annexin VI
where the GAP C2 domain binds, a series of GST annexin VI
fusion proteins were ¢rst expressed in E. coli and puri¢ed to
homogeneity. Fig. 1A shows a schematic diagram of the ami-
no acid sequence boundaries for each fusion protein made.
Each fusion protein contained between 100^170 amino acids
of sequence corresponding to the human annexin VI protein
sequence. Each fusion protein was expressed and analysed by
SDS-PAGE (Fig. 1B) and then the GST sequence was cleaved
free from the fusion protein by digestion with Factor Xa to
yield puri¢ed annexin VI protein fragments (Fig. 1C). These
protein fragments were then assayed by Western blotting for
their ability to be detected by either anti-GST antibodies or
anti-annexin VI antibodies. All puri¢ed annexin VI protein
fragments were detected by anti-annexin VI antibodies (Fig.
1E) but no cross-reactivity with anti-GST antibodies was ob-
served (Fig. 1D).
3.2. Far Western overlay binding assay for GAP C2 domain
binding
First round screening for GAP C2 domain binding was
undertaken using either full length annexin VI recombinant
protein (Fig. 2A) or annexin VI protein fragments prepared
and analysed as described above (Fig. 2B and C). Using a
GST GAP C2 domain fusion protein and anti-GST antibodies
to detect fusion protein binding, Far Western overlay binding
was employed. Full length annexin VI or each annexin VI
protein fragment was electrophoretically transferred from
SDS-polyacrylamide gels onto nitrocellulose ¢lters and after
blocking, the ¢lters were incubated with either GST control
(Fig. 2A and B) or GSTGAP C2 domain (Fig. 2A and C)
Fig. 3. A: Far Western overlay binding of annexin VI292ÿ421 to GSTGAP C2 in the presence and absence of recombinant annexin VI demon-
strates a competitive displacement of annexin VI292ÿ421 with free annexin VI. B: GSTannexin VI292ÿ421 interferes with the co-immunoprecipita-
tion of annexin VI and anti-GAP from Rat-1 ¢broblast cell lysates.
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fusion proteins. GSTGAP C2 domain fusion protein was only
detected as binding to the full length annexin VI protein and
the annexin VI protein fragment corresponding to amino acid
sequence 292^421 of human annexin VI.
3.3. Competition studies to con¢rm the GAP C2 domain
interaction site
In order to con¢rm the importance of the annexin VI re-
gion 292^421 in the binding of the GAP C2 domain, two
competition assays were employed. Firstly, using the protein
fragment annexin VI292ÿ421 immobilised on the nitrocellulose
¢lter, a Far Western overlay assay was undertaken in the
presence or absence of full length recombinant annexin VI
(Fig. 3A). When 30-fold molar excess annexin VI was present,
the binding of the GAP C2 domain to the immobilised protein
fragment was competed out. However, in order to establish
whether this protein fragment could indeed interact with na-
tive cellular annexin VI protein, its ability to disrupt the in-
teraction between full length GAP and annexin VI in Rat-1
¢broblast cell lysates was investigated. To do this, a GST
control or GST annexin VI292ÿ421 fusion protein was included
during immunoprecipitation of cell lysates with either pre-im-
mune control sera or anti-GAP antibodies (Fig. 3B). Immu-
noprecipitated protein complexes were resolved by SDS-
PAGE and separated proteins were Western transferred
onto nitrocellulose ¢lters. Blots were then probed for the pres-
ence of GAP and annexin VI proteins. GAP and annexin VI
were speci¢cally observed to co-immunoprecipitate when us-
ing anti-GAP antibodies and whilst the presence of the GST
annexin VI292ÿ421 fusion protein did not signi¢cantly interfere
with the ability of the anti-GAP antibodies to immunopreci-
pitate GAP protein from cell lysates (when compared with the
GST protein control), the amount of co-immunoprecipitating
annexin VI detected in the complex was signi¢cantly de-
creased (Fig. 3B). Indeed, scanning densitometry measure-
ments estimated that the presence of the fusion protein de-
creased the amount of co-complexing annexin VI by
approximately 70%.
3.4. V8 digestion studies
Molecular models based on X-ray crystallographic structur-
al data for annexin VI indicated that the region containing
amino acid sequence 292^421 corresponds to part of domain
IV in lobe 1, the interconnecting ‘linker’ region and part of
domain V within lobe two of the protein [3,4]. It was therefore
necessary to further de¢ne the interaction site within the struc-
tural regions known to exist within the protein. To do this,
protease digestion studies were undertaken. A schematic dia-
gram of the structural units within annexin VI is shown in
Fig. 4A and V8 protease-sensitive cleavage sites as de¢ned by
Ishitsuka et al. [18] are indicated. V8 digestion of recombinant
human annexin VI was undertaken in order to produce char-
Fig. 4. A: Schematic diagram representing the V8 proteolytic fragments of annexin VI. B: Coomassie-stained SDS-polyacrylamide gel of puri-
¢ed V8 cleaved annexin VI fragments. C: The 33 kDa fragment binds to GSTGAP C2.
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acteristic peptides derived from protein sequence within the
already de¢ned interaction site. Three characteristic 33, 19
and 12kDa proteolytic fragments previously described by Ish-
itsuka et al. were obtained (Fig. 4B). These protein fragments
were Western transferred onto nitrocellulose ¢lters and then
subjected to Far Western overlay binding assay with either
GST control or GST GAP C2 domain fusion proteins (Fig.
4C). The GST GAP C2 domain fusion protein was only de-
tected as binding to the 33 kDa proteolytic fragment.
3.5. The annexin VI interconnecting ‘Linker’ region contains
the GAP C2 domain binding site
Comparison of the overlapping region between the annexin
VI292ÿ421 fragment and the 33 kDa V8 digestion peptide in-
dicated that the GAP C2 domain interaction site is located
between amino acid residues 292^351 (see Fig. 4A). However,
since molecular modelling studies indicated that a discrete
structural region known as the ‘Linker’ region is found be-
tween residues 325^363 of annexin VI, it was possible that the
GAP C2 domain binding site could be located within this
‘Linker’ region. To test this, a GST fusion protein was con-
structed to correspond to this Linker region and the protein
fragment was again liberated by cleavage from the fusion
protein. GAP C2 domain interaction was tested for using
¢rstly Far Western overlay binding assay (Fig. 5A) and cel-
lular protein competition assay (Fig. 5B). The annexin
VI325ÿ363 protein fragment was indeed found to bind to the
GST GAP C2 domain fusion protein. Also, the GST annexin
VI325ÿ363 fusion protein was able to remove the ability of
cellular full length GAP to co-immunoprecipitate with cellular
full length annexin VI protein when this fusion protein (but
not GST control protein) was loaded into cells by electropo-
ration (Fig. 5B). Hence, we have de¢ned 27 amino acid resi-
dues (annexin VI325ÿ351) located within the annexin VI inter-
lobe connecting region as being important for the binding of
the GAP C2 domain to annexin VI in cells.
4. Discussion
In this study we have identi¢ed the structural region within
annexin VI where the GAP C2 domain binds. We have
mapped the interaction site to within 27 amino acid residues
which are located within the inter-lobe linking region of the
annexin VI protein. The results of this study strongly indicate
that the interaction between GAP and annexin VI is a highly
speci¢c protein-protein interaction because all other annexin
family members so far identi¢ed are characteristically com-
prised of one tetrad repeat of 70 amino acid residue domains
whereas annexin VI is unique in that it is comprised of two
such tetrad repeats co-joined by this inter-lobe linker region.
Intriguingly, crystal structure data indicate that the ¢rst lobe
is rotated about 90‡ relative to the second lobe when in the
crystal structure and in solution. However, when bound to a
lipid monolayer both lobes appear to be coplanar [19]. Thus, a
signi¢cant change in conformation must occur upon binding
of the protein to membranes and the inter-lobe linker region
must display corresponding £exibility. How such a £exibility
could be involved in its ability to interact with GAP or if
Fig. 5. A: Far Western overlay analysis demonstrates puri¢ed annexin VI325ÿ363 binds to GSTGAP C2 but not GST. B: Immunoprecipitation
of GAP from Rat-1 ¢broblasts loaded with GSTannexin VI325ÿ363 but not GST protein blocks the co-immunoprecipitation of annexin VI.
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indeed whether the presence of this protein-protein interaction
could in£uence the ability of annexin VI to rotate its lobes
and interact with cellular membranes are clearly intriguing
areas for further investigation.
Finally, if, as has been suggested previously this annexin
structure has arisen as a result of a series of gene duplications
and fusions during evolution [20,21], then such an evolution-
ary adaptation has presumably resulted in a corresponding
cellular function associated with GAP and thereby possibly
the Ras signalling pathway. It is now our aim to disrupt
this protein-protein interaction and study the cellular conse-
quences of this action.
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